These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26037421)

  • 1. Rotavirus vaccines at the threshold of implementation in India.
    Tate JE; Arora R; Kang G; Parashar UD
    Natl Med J India; 2014; 27(5):245-8. PubMed ID: 26037421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for routine childhood vaccination against rotavirus in India.
    Parashar U; Tate J; Arora R; Kang G
    Natl Med J India; 2012; 25(5):257-60. PubMed ID: 23448622
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim.
    Megiddo I; Colson AR; Nandi A; Chatterjee S; Prinja S; Khera A; Laxminarayan R
    Vaccine; 2014 Aug; 32 Suppl 1():A151-61. PubMed ID: 25091670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
    Patel MM; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus gastroenteritis in India, 2011-2013: revised estimates of disease burden and potential impact of vaccines.
    John J; Sarkar R; Muliyil J; Bhandari N; Bhan MK; Kang G
    Vaccine; 2014 Aug; 32 Suppl 1():A5-9. PubMed ID: 25091681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesizing evidences for policy translation: a public health discourse on rotavirus vaccine in India.
    Panda S; Das A; Samanta S
    Vaccine; 2014 Aug; 32 Suppl 1():A162-70. PubMed ID: 25091671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights from global data for use of rotavirus vaccines in India.
    Rao TS; Arora R; Khera A; Tate JE; Parashar U; Kang G;
    Vaccine; 2014 Aug; 32 Suppl 1():A171-8. PubMed ID: 25091672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotavirus disease and vaccines in India: a tremendous public health opportunity.
    Tate JE; Arora R; Bhan MK; Yewale V; Parashar UD; Kang G
    Vaccine; 2014 Aug; 32 Suppl 1():vii-xii. PubMed ID: 25091690
    [No Abstract]   [Full Text] [Related]  

  • 10. Rotavirus vaccines: update on global impact and future priorities.
    Yen C; Tate JE; Patel MM; Cortese MM; Lopman B; Fleming J; Lewis K; Jiang B; Gentsch J; Steele D; Parashar UD
    Hum Vaccin; 2011 Dec; 7(12):1282-90. PubMed ID: 22108032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotavirus vaccine impact assessment surveillance in India: protocol and methods.
    Nair NP; Reddy N S; Giri S; Mohan VR; Parashar U; Tate J; Shah MP; Arora R; Gupte M; Mehendale SM; ; Kang G
    BMJ Open; 2019 Apr; 9(4):e024840. PubMed ID: 31028037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global impact of rotavirus vaccines.
    Tate JE; Patel MM; Steele AD; Gentsch JR; Payne DC; Cortese MM; Nakagomi O; Cunliffe NA; Jiang B; Neuzil KM; de Oliveira LH; Glass RI; Parashar UD
    Expert Rev Vaccines; 2010 Apr; 9(4):395-407. PubMed ID: 20370550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the introduction of universal rotavirus vaccination in the Netherlands.
    Zomer TP; van Duynhoven YT; Mangen MJ; van der Maas NA; Vennema H; Boot H; de Melker HE
    Vaccine; 2008 Jul; 26(29-30):3757-64. PubMed ID: 18514975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the United Kingdom.
    Lorgelly PK; Joshi D; Iturriza Gómara M; Gray J; Mugford M
    Epidemiol Infect; 2008 Jan; 136(1):44-55. PubMed ID: 17335631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluations of rotavirus immunization for developing countries: a review of the literature.
    Tu HA; Woerdenbag HJ; Kane S; Rozenbaum MH; Li SC; Postma MJ
    Expert Rev Vaccines; 2011 Jul; 10(7):1037-51. PubMed ID: 21806398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.
    Nakagomi T; Cuevas LE; Gurgel RG; Elrokhsi SH; Belkhir YA; Abugalia M; Dove W; Montenegro FM; Correia JB; Nakagomi O; Cunliffe NA; Hart CA
    Arch Virol; 2008; 153(3):591-3. PubMed ID: 18175037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.
    Justino MC; Linhares AC; Lanzieri TM; Miranda Y; Mascarenhas JD; Abreu E; Guerra SF; Oliveira AS; da Silva VB; Sanchez N; Meyer N; Shafi F; Ortega-Barria E; Soriano-Gabarró M; Colindres RE
    Pediatr Infect Dis J; 2011 May; 30(5):396-401. PubMed ID: 21150692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 116E rotavirus vaccine may have less impact in India than projected.
    Piple JK; Puliyel J
    Vaccine; 2015 Dec; 33(51):7142. PubMed ID: 26675193
    [No Abstract]   [Full Text] [Related]  

  • 19. The pentavalent rotavirus vaccine, RotaTeq.
    Matson DO
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):195-9. PubMed ID: 17055370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa.
    Pawinski R; Debrus S; Delem A; Smolenov I; Suryakiran PV; Han HH
    J Infect Dis; 2010 Sep; 202 Suppl():S80-6. PubMed ID: 20684722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.